Tumors were eradicated in 30% of mice receiving cGAS LNPs injected into the tumor, in combination with immune checkpoint blockade.

In a groundbreaking development for the field of oncology, artificial intelligence (AI) has unearthed patterns in breast ...

Northwestern Medicine scientists have discovered how a specific transcription factor promotes genetic reprogramming and ...

The field of oncology continues to confront the formidable challenge of addressing cancer, a leading cause of mortality ...

Introduction: Detailed, comprehensive, and timely reporting on cancer incidence, mortality, and associated burdens is essential for understanding the evolving trends of this complex disease. This ...

There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...

Patients were randomized to receive I-DXd 8 or 12 mg/kg intravenously every 3 weeks (Q3W) in part 1 (dose optimization) and received I-DXd 12 mg/kg in part 2 (extension). The primary endpoint was ...

Pooled analysis supports the rationale for the ongoing MAIA-ovarian trial evaluating COM701 as maintenance therapy in the earlier setting of platinum sensitive ovarian cancer "There is a gap in care ...

Is the Use of an Agent or Test in a Clinical Trial Slippery or Sticky? We conducted a randomized controlled trial at two integrated health systems. Inclusion criteria were age 18+ years and receiving ...

Department of Laboratory Medicine, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Core Unit of National Clinical Research ...

MIT and Harvard scientists have created engineered CAR-NK cells that can hide from the immune system and more effectively destroy cancer. The cells are designed to suppress immune-rejection signals ...